76 filings
Page 3 of 4
8-K
f6ab6c7rcx69krsuk
18 Oct 21
Other Events
4:08pm
8-K
d1n4r8sn
27 Sep 21
Other Events
7:54am
8-K
neyu7528w8nozhe
15 Sep 21
Regulation FD Disclosure
4:05pm
8-K
idb fy2wb7x
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
8-K
xnet8gvaa jj
10 Aug 21
Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results
4:05pm
8-K
nuauovy49ddgfj9 9zp
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
seuj xltmfl
28 Jun 21
Other Events
7:30am
8-K
075s7iw
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:55pm
8-K
9k08j
6 May 21
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results
4:01pm
8-K
ivey11582myijz 5w2cz
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
njl i30gl6e
30 Mar 21
Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results
5:05pm
8-K
24ih7 2l9n054cqhn
4 Feb 21
Other Events
7:00am
8-K
qof5x1xyarb unoh
3 Feb 21
Other Events
7:00am
8-K
m43lhwhzzq oigbbe
6 Jan 21
Other Events
7:00am
8-K
tuknf
6 Nov 20
Crinetics Pharmaceuticals Reports Third Quarter 2020 Financial Results
8:30am
8-K
txm1xj
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
5xzkdvx4pwxg8if4w3
21 Sep 20
Other Events
7:30am
8-K
j7w w5r7uergc4
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
bxi tymzn15z2
7 Aug 20
Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results
7:30am
8-K
9et o7k2dxigtqf
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm